SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BERNARDI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.593
EU - Europa 6.595
AS - Asia 5.038
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 13
AF - Africa 8
Totale 36.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.499
CN - Cina 2.460
UA - Ucraina 1.642
IT - Italia 1.375
DE - Germania 1.237
SG - Singapore 1.175
TR - Turchia 1.011
GB - Regno Unito 670
SE - Svezia 422
PL - Polonia 409
FI - Finlandia 385
ID - Indonesia 148
BE - Belgio 94
CA - Canada 89
FR - Francia 77
RU - Federazione Russa 60
CZ - Repubblica Ceca 56
HK - Hong Kong 55
NL - Olanda 52
IN - India 45
VN - Vietnam 45
IR - Iran 36
JP - Giappone 20
AU - Australia 19
CH - Svizzera 17
RO - Romania 16
IE - Irlanda 13
LT - Lituania 13
EU - Europa 12
KR - Corea 11
ES - Italia 9
GR - Grecia 9
TW - Taiwan 7
DK - Danimarca 6
NZ - Nuova Zelanda 6
PE - Perù 6
PT - Portogallo 6
GE - Georgia 5
NO - Norvegia 5
AL - Albania 4
BG - Bulgaria 4
BR - Brasile 4
IL - Israele 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
HU - Ungheria 3
PK - Pakistan 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DZ - Algeria 2
KE - Kenya 2
MK - Macedonia 2
MY - Malesia 2
TH - Thailandia 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
HN - Honduras 1
IQ - Iraq 1
JO - Giordania 1
LU - Lussemburgo 1
MA - Marocco 1
MT - Malta 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 36.286
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.987
Fairfield 2.928
Chandler 1.929
Houston 1.868
Jacksonville 1.835
Ashburn 1.418
Ann Arbor 1.407
Seattle 1.174
Wilmington 1.105
Cambridge 962
Santa Clara 934
Singapore 914
Izmir 629
Nanjing 571
Ferrara 468
Princeton 436
Warsaw 407
Boardman 396
Beijing 383
New York 323
San Diego 269
Shanghai 194
Milan 191
Dearborn 173
Nanchang 171
Shenyang 169
Bremen 162
Jakarta 145
Hebei 120
Jiaxing 110
Los Angeles 107
Tianjin 105
Falls Church 104
Changsha 91
Redwood City 86
Brussels 85
Jinan 81
Norwalk 72
San Mateo 71
London 70
Kunming 66
Mountain View 65
Munich 61
Düsseldorf 51
Auburn Hills 49
Brno 48
Toronto 48
Zhengzhou 45
Dong Ket 44
Helsinki 43
Addison 42
Hong Kong 42
Des Moines 41
Guangzhou 37
Ningbo 37
Rome 37
Orange 31
Bologna 29
Frankfurt am Main 27
Hangzhou 27
Taizhou 27
Washington 26
Verona 25
Ottawa 23
Augusta 22
Chicago 21
Leawood 21
Philadelphia 20
Indiana 19
Monmouth Junction 19
Padova 19
Redmond 18
Ardabil 15
Florence 15
Fuzhou 14
Hefei 14
Mcallen 13
Paris 13
Lanzhou 12
Tappahannock 12
Hounslow 11
Haikou 10
Montréal 10
Napoli 10
Piemonte 9
Amsterdam 8
Catania 8
Changchun 8
Naples 8
San Francisco 8
Tokyo 8
Andover 7
Chengdu 7
Ferrara di Monte Baldo 7
Hyderabad 7
Kilburn 7
Pavia 7
Shenzhen 7
Taiyuan 7
Wuhan 7
Totale 27.049
Salva come PNG Salva come JPEG
Nome #
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 310
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 220
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 195
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 189
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 188
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 180
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 176
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 168
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 165
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 162
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 162
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 158
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 154
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 154
Hemostasis biomarkers in multiple sclerosis 150
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 148
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 146
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 145
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 145
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 144
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 144
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 141
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 140
Chronic sleep deprivation markedly reduces coagulation factor VII expression 138
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 137
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 137
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 137
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 135
Characterization of a deleted Y chromosome in a male with Turner stigmata 132
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 131
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 130
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 129
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 128
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. 127
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 126
null 125
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 125
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 125
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 124
Taqi polymorphism at the human coagulation factor XII locus (F12) 124
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 124
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 124
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 123
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 123
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 123
Plasma levels of soluble NCAM in multiple sclerosis 122
null 121
Circadian rhythms in mouse blood coagulation 121
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 121
Better or worse than the original 121
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 121
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 120
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 120
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 119
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 119
PvuII RFLP inside the human estrogen receptor gene 119
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 118
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 118
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 117
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B 117
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 117
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 117
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 117
Membrane binding and anticoagulant properties of protein S natural variants 116
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 116
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 116
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 115
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 115
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. 114
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 114
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 114
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 113
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia 113
Detection and characterization of polymorphic markers in the factor-VII gene. 113
Partial gene deletion in a family with factor X deficiency 113
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 112
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 112
Factor IX propeptide mutation and life threatening bleeding 111
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 111
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 111
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 110
Rescue of coagulation factor VII function by the U1+5A snRNA 110
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 110
null 109
An underestimated combination of opposites resulting in enhanced thrombotic tendency 109
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 109
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 109
Phytochemical Analysis and Cytotoxicity Towards Multidrug-Resistant Leukemia Cells of Essential Oils Derived from Lebanese Medicinal Plants 109
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 109
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 109
Assignment of human coagulation factor XII (fXII) to chromosome 5 by cDNA hybridization to DNA from somatic cell hybrids 108
Factor VII mutant V154G models a zymogen-like form of factor VIIa 108
RNA-based therapeutic approaches for coagulation factor deficiencies 108
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 108
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 107
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 107
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis 107
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 107
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 106
The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels. 106
Totale 12.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.051
Totale 174.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.647 0 0 0 0 489 918 679 742 579 797 291 152
2020/20215.461 458 420 291 642 185 500 331 627 180 801 735 291
2021/20224.434 245 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.440 488 342 109 583 726 661 211 356 543 39 244 138
2023/20242.348 203 277 110 81 166 433 65 154 59 56 64 680
2024/20252.685 266 186 817 272 1.144 0 0 0 0 0 0 0
Totale 36.955